Overview
Hongmei Li practices practicing medicine in Nanjing, China.
Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Bone Tumor, Prostate Cancer, and Leukemia.
They are actively involved in clinical research, co-authoring 59 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hongmei Q. Li
Is Hongmei Q. Li a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Hongmei Q. Li is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hongmei Q. Li participate in research or clinical trials?
Yes. Hongmei Q. Li has published 59 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Hongmei Q. Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)
- Bone TumorLi isExperienced. Learn about Bone Tumor.
- LeukemiaLi isExperienced. Learn about Leukemia.
- Prostate CancerLi isExperienced. Learn about Prostate Cancer.